Works matching IS 09509232 AND DT 2008 AND VI 27 AND IP 19

Results: 15

Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2728, doi. 10.1038/sj.onc.1210921

By:

Colomba, A.;
Courilleau, D.;
Ramel, D.;
Billadeau, D. D.;
Espinos, E.;
Delsol, G.;
Payrastre, B.;
Gaits-Iacovoni, F.

Publication type:

Article

Neuregulin and laminin stimulate phosphorylation of the NF2 tumor suppressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2705, doi. 10.1038/sj.onc.1210923

By:

Thaxton, C.;
Lopera, J.;
Bott, M.;
Fernandez-Valle, C.

Publication type:

Article

Ras isoform abundance and signalling in human cancer cell lines.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2754, doi. 10.1038/sj.onc.1210925

By:

Omerovic, J.;
Hammond, D. E.;
Clague, M. J.;
Prior, I. A.

Publication type:

Article

Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2737, doi. 10.1038/sj.onc.1210926

By:

Sasaki, H.;
Hayakawa, J.;
Terai, Y.;
Kanemura, M.;
Tanabe-Kimura, A.;
Kamegai, H.;
Seino-Noda, H.;
Ezoe, S.;
Matsumura, I.;
Kanakura, Y.;
Sakata, M.;
Tasaka, K.;
Ohmichi, M.

Publication type:

Article

HIFα expression in VHL-deficient renal cancer cells is dependent on phospholipase D.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2746, doi. 10.1038/sj.onc.1210927

By:

Toschi, A.;
Edelstein, J.;
Rockwell, P.;
Ohh, M.;
Foster, D. A.

Publication type:

Article

Gab2 and Src co-operate in human mammary epithelial cells to promote growth factor independence and disruption of acinar morphogenesis.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2693, doi. 10.1038/sj.onc.1210928

By:

Bennett, H. L.;
Brummer, T.;
Jeanes, A.;
Yap, A. S.;
Daly, R. J.

Publication type:

Article

The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2661, doi. 10.1038/sj.onc.1210935

By:

Balakrishnan, S. K.;
Gross, D. S.

Publication type:

Article

Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2788, doi. 10.1038/sj.onc.1210932

By:

Reinbold, M.;
Luo, J.-L.;
Nedelko, T.;
Jerchow, B.;
Murphy, M. E.;
Whibley, C.;
Wei, Q.;
Hollstein, M.

Publication type:

Article

Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2673, doi. 10.1038/sj.onc.1210933

By:

Daubon, T.;
Chasseriau, J.;
El Ali, A.;
Rivet, J.;
Kitzis, A.;
Constantin, B.;
Bourmeyster, N.

Publication type:

Article

Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2716, doi. 10.1038/sj.onc.1210934

By:

Hurst, C. D.;
Tomlinson, D. C.;
Williams, S. V.;
Platt, F. M.;
Knowles, M. A.

Publication type:

Article

Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2686, doi. 10.1038/sj.onc.1210929

By:

Silva, F. Pittella;
Hamamoto, R.;
Kunizaki, M.;
Tsuge, M.;
Nakamura, Y.;
Furukawa, Y.

Publication type:

Article

Thyroid hormone receptor-β (TRβ1) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2795, doi. 10.1038/sj.onc.1210936

By:

Porlan, E.;
Vidaurre, O. G.;
Rodríguez-Peña, A.

Publication type:

Article

Activation of the p53–p21Cip1 pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2763, doi. 10.1038/sj.onc.1210937

By:

Wierød, L.;
Rosseland, C. M.;
Lindeman, B.;
Oksvold, M. P.;
Grøsvik, H.;
Skarpen, E.;
Huitfeldt, H. S.

Publication type:

Article

C/EBPα:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBPα homodimers or AP-1.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2772, doi. 10.1038/sj.onc.1210940

By:

Cai, D. H.;
Wang, D.;
Keefer, J.;
Yeamans, C.;
Hensley, K.;
Friedman, A. D.

Publication type:

Article

p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis.

Published in:

Oncogene, 2008, v. 27, n. 19, p. 2780, doi. 10.1038/sj.onc.1210941

By:

Johnson, J.;
Lagowski, J.;
Lawson, S.;
Liu, Y.;
Kulesz-Martin, M.

Publication type:

Article

Works matching IS 09509232 AND DT 2008 AND VI 27 AND IP 19

Activation of Rac1 and the exchange factor Vav3 are involved in NPM-ALK signaling in anaplastic large cell lymphomas.

Neuregulin and laminin stimulate phosphorylation of the NF2 tumor suppressor in Schwann cells by distinct protein kinase A and p21-activated kinase-dependent pathways.

Ras isoform abundance and signalling in human cancer cell lines.

Difference between genomic actions of estrogen versus raloxifene in human ovarian cancer cell lines.

HIFα expression in VHL-deficient renal cancer cells is dependent on phospholipase D.

Gab2 and Src co-operate in human mammary epithelial cells to promote growth factor independence and disruption of acinar morphogenesis.

The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model.

Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72.

Differential motility of p190<sup>bcr-abl</sup>- and p210<sup>bcr-abl</sup>-expressing cells: respective roles of Vav and Bcr-Abl GEFs.

Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.

Enhanced methyltransferase activity of SMYD3 by the cleavage of its N-terminal region in human cancer cells.

Thyroid hormone receptor-β (TRβ1) impairs cell proliferation by the transcriptional inhibition of cyclins D1, E and A2.

Activation of the p53–p21<sup>Cip1</sup> pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes.

C/EBPα:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBPα homodimers or AP-1.

p73 expression modulates p63 and Mdm2 protein presence in complex with p53 family-specific DNA target sequence in squamous cell carcinogenesis.